IRF1 and psoriasis: This dual action of potent NRF2 activation alongside strong repression of NF-κB and IRF1 signaling is particularly significant, as it reflects a balanced therapeutic profile by promoting cytoprotective, antioxidant defenses whilst simultaneously dampening the pathological inflammation central to skin diseases like psoriasis [134].